Chronicles of a Small Manufacturer Dreaming of Re-enchanting France – Episode 4: Go Live, Bioproduction, and the Revolution of Cell Therapies: France in Action!
This week, two major industrial milestones:
-Go Live at MGA! Another batch of cutting-edge industrial solutions ready to ship, pushing the boundaries of biotech, techbio, medtech, and health innovation.
-The launch of The Drug Cell (TDC), a game-changer for cell therapies in Europe! Backed by €152M under the France 2030 initiative, this new French alliance will drive scalable, AI-powered cell therapy manufacturing.
With Digital Twin technology, real-time quality control, and automated processes, TDC is set to redefine regenerative medicine in Europe. A strong partnership between leading biotech innovators, including EFS, MGA, GPI France, Carroucell, EVerZom, and top medical research centers.
In the Same Category
Chronicles of a small industrialist who dreams of re-enchanting France – Episode 52
In 2050, French industry has rediscovered its genius. Rooted in history, driven by innovation. AI, energy and biology work together, not against each other. Factories are human-centric, sustainable and intelligent. Maison MGA stands at the crossroads of science,...
They are talking about us – Maison MGA and acquisition of Myriade
La Maison MGA has recently been featured in several regional and specialized media outlets, which have reported on our industrial and strategic news. In Lyon Éco et Culture, the acquisition of Myriade is presented as an important step in strengthening our expertise in...